| Date Filed | Type | Description |
| 02/06/2023 |
4
| Jones Erin (See Remarks) has filed a Form 4 on Gritstone bio, Inc.|
Txns:
| Granted 252,845 shares
@ $0 |
|
| 04/20/2022 |
4
| Jones Erin (COO) has filed a Form 4 on Gritstone bio, Inc.|
Txns:
| Granted 27,169 shares
@ $0
Granted 163,013 options to buy
@ $5.46, valued at
$890.1k
|
|
| 12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 12/03/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 11/19/2021 |
4
| Jones Erin (See Remarks) has filed a Form 4 on Gritstone bio, Inc.|
Txns:
| Granted 25,900 shares
@ $0 |
|
| 11/19/2021 |
4/A
| Jones Erin (See Remarks) has filed a Form 4 on Gritstone bio, Inc.|
Txns:
| Sold 2,000 shares
@ $11.3738, valued at
$22.7k
Exercised 2,000 options to buy
@ $0.345, valued at
$690 |
|
| 11/03/2021 |
4
| Jones Erin (See Remarks) has filed a Form 4 on Gritstone bio, Inc.|
Txns:
| Sold 1,000 shares
@ $11.14, valued at
$11.1k
Exercised 1,000 options to buy
@ $0.345, valued at
$345 |
|
| 10/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2020 |
4
| Jones Erin (See Remarks) has filed a Form 4 on Gritstone Oncology, Inc.|
Txns:
| Exercised 10,000 options to buy
@ $0.345, valued at
$3.5k
|
|
| 02/27/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2019 |
4
| Jones Erin (See Remarks) has filed a Form 4 on Gritstone Oncology, Inc.|
Txns:
| Granted 66,000 options to buy
@ $12.02, valued at
$793.3k
|
|
| 03/06/2019 |
4
| Jones Erin (See Remarks) has filed a Form 4 on Gritstone Oncology, Inc.|
Txns:
| Exercised 10,000 options to buy
@ $0.345, valued at
$3.5k
|
|
| 09/27/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |